$2-million investment accelerates psychedelic medicine research at St. Joseph’s Healthcare Hamilton - www.hospitalnews.com
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
St. Joseph’s Healthcare Hamilton is expanding research into the potential medical use of psychedelics following two $1-million philanthropic investments in its new Centre for Health Innovation and Research in Psychedelics (CHIRP).
The $2 million in combined funding comes from Hamilton philanthropist Teresa Cascioli and The Juravinski Foundation and represents the first major philanthropic investments in the centre, which was launched last fall.
This article is an excerpt. To read the full content, visit the original source. www.hospitalnews.com
Related articles
Olympian Clara Hughes on menopause and psychedelic therapy: 'I had to go hard' - Toronto Star
Olympian Clara Hughes’s new memoir, “Learning to Breathe,” chronicles her experience with menopause, psychedelic therapy and long-buried memories of abuse. Clara Hughes spent two decades teaching her body to obey her — through pain, exhaustion and sheer force of will — on her way to becoming the only athlete in history to win multiple medals at both the Summer and Winter Olympics. Then, in her late 40s, her body stopped listening.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!